Prothena Corporation PLC
NASDAQ:PRTA

Watchlist Manager
Prothena Corporation PLC Logo
Prothena Corporation PLC
NASDAQ:PRTA
Watchlist
Price: 16.1 USD -6.56% Market Closed
Market Cap: 865.9m USD
Have any thoughts about
Prothena Corporation PLC?
Write Note

Wall Street
Price Targets

PRTA Price Targets Summary
Prothena Corporation PLC

Wall Street analysts forecast PRTA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PRTA is 62.37 USD with a low forecast of 24.24 USD and a high forecast of 98.7 USD.

Lowest
Price Target
24.24 USD
51% Upside
Average
Price Target
62.37 USD
287% Upside
Highest
Price Target
98.7 USD
513% Upside

PRTA Last Price Targets
Prothena Corporation PLC

The latest public price target was made on Aug 14, 2024 by Jay Olson from Oppenheimer , who expects PRTA stock to rise by 285% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Jay Olson
Oppenheimer
62 USD
Upside 285%
3 months ago
Aug 14, 2024
Prothena Corp (PRTA) PT Lowered to $62 at Oppenheimer
StreetInsider
Kennen MacKay
RBC Capital
24 USD
Upside 49%
3 months ago
Aug 9, 2024
Prothena Corp (PRTA) PT Lowered to $24 at RBC Capital
StreetInsider
Kennen MacKay
RBC Capital
28 USD
Upside 74%
6 months ago
May 9, 2024
Prothena Corp (PRTA) PT Lowered to $28 at RBC Capital
StreetInsider
Jay Olson
Oppenheimer
Price Target 62 USD
Upside/Downside 285%
View Source
Kennen MacKay
RBC Capital
Price Target 24 USD
Upside/Downside 49%
View Source
Kennen MacKay
RBC Capital
Price Target 28 USD
Upside/Downside 74%
View Source
Prothena Corporation PLC Competitors:
Price Targets
MCRB
Seres Therapeutics Inc
571% Upside
STTK
Shattuck Labs Inc
49% Upside
BLAU3
Blau Farmaceutica SA
7% Upside
GNS
Genus PLC
44% Upside
688192
Dizal Jiangsu Pharmaceutical Co Ltd
21% Upside
AGIO
Agios Pharmaceuticals Inc
1% Upside
MOLN
Molecular Partners AG
89% Upside
377740
BioNote Inc
23% Upside

Revenue
Forecast

Revenue Estimate
Prothena Corporation PLC

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 66%. The projected CAGR for the next 3 years is 36%.

66%
Past Growth
36%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
Prothena Corporation PLC

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PRTA's stock price target?
Price Target
62.37 USD

According to Wall Street analysts, the average 1-year price target for PRTA is 62.37 USD with a low forecast of 24.24 USD and a high forecast of 98.7 USD.

What is Prothena Corporation PLC's Revenue forecast?
Projected CAGR
36%

For the last 8 years the compound annual growth rate for Prothena Corporation PLC's revenue is 66%. The projected CAGR for the next 3 years is 36%.

Back to Top